Johns Hopkins Center for Clinical Trials

 

HOME

RESEARCH
 • ADAPT
 • ALA-ACRC
 • US Cochrane Ctr
 • CEVG
 • DIADS-2
 • MUST
 • PVAS
 • SOCA
 • SHHS
 • TrialsCentral
 • A+ Asthma
 • CBET
 • IONDT
 • STOP-DUB
 • WGET

FACULTY & STAFF

SEMINARS

EDUCATIONAL PROGRAMS

EMPLOYMENT

RESOURCES

 

RESEARCH STUDIES

Depression in Alzheimer's Disease Study - Phase 2 (DIADS-2)

Publications

CEVG@US is funded by the National Eye Institute of the National Institutes of Health. The overall objective of the project is to develop a critical mass of US-based vision researchers and practitioners who are trained in preparing and using systematic reviews as part of the CEVG. The CEVG@US group aims to accomplish four main goals: expand awareness of evidence-based health care in general and in eyes and vision specifically; develop a critical mass of vision researchers who are able to perform and interpret systematic reviews, and train others to do the same; develop a critical mass of clinicians who use the results of systematic reviews as an evidence base to guide their practice, and to train others to do the same; generate an increased number of systematic reviews in priority vision research areas, published in The Cochrane Library and in the traditional vision research literature.

 

 

Johns Hopkins Bloomberg School of Public Health
 

  © 2006, Johns Hopkins University. All rights reserved.
 Web policies, 615 N. Wolfe Street, Baltimore, MD 21205, 443-287-7277